This monoclonal antibody is responsible for the destruction of the specific cells of the body. This medication was prescribed by doctors for the elimination of the multiple sclerosis.. However this medication was later banned for various reasons. To be frank, this medication was defective and lethal for speeding up the risks of virus infection of the brain. This type of fatal brain infection can snowball into death. There are other prominent symptoms which will make patients weak and incompetent after the consumption of this medication. A patient will have to run the risk of getting attacked by the mental disorder, stress, low vision and difficulty to move freely and speak fluently and normally.
A gentleman must undergo the TOUCH Prescribing Program Testing to get this medication. Applicants will be cross-examined and interviewed before giving the medication to patients. It is also important that before opting for this medication, doctors must check the patients thoroughly whether they are out of the risk of any body infection or any type of lethal disease. Under any circumstance, in case a patient feels any sign of abnormality in the functionality of the liver or if there are symptoms of discharging dark colored urine, itching, jaundice and so on after the intake of this medication, he must go to the doctor for the treatment. There is another serious brain infection called multifocal leukoencephalopathy. If any patient is affected by this brain disease, he should consult medicos before the usage of this medication. In addition, if anyone is also under the risk of AIDS or herpes inclusive of any sexually transmitted disease, he must seek for the consultation of the doctors before the intake of Tyabri.
There are other factors which must be committed to memory at the time of the consumption of the medication. In case of the replacement of any organ, usage of the steroid medication or any type of radiation and chemotherapy, special treatment procedure is needed with the consumption of this medication. The body must be rechecked by the doctors and confirm whether this medication will bring the least danger to the body. Lastly, females who like to be pregnant or being already pregnant should steer clear of taking this medication which can damage the health of the unborn kids in the female womb. During the breast feeding, mother should not use this medication as well as a part of the safeguards to the body from the onset of any infection.
Tysabri®, which also goes by the generic name natalizumab,
was designed to slow the progression of disabilities relating to
multiple sclerosis. Further studies showed it could also help with
the gastrointestinal ailment Chron's Disease as well as
rheumatoid arthritis.
Since the FDA approved Tysabri® in November, approximately
5,000 patients received intravenous infusions. An additional 3,000
patients received Tysabri® in clinical trials.
